| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Can Protocol Biopsy Better Inform Our Choices in Renal Transplantation?
|
Rush, D.
|
|
2009
|
41 |
6S |
p. S6-S8
3 p.
|
artikel
|
| 2 |
De Novo Immunosuppression With Mammalian Target of Rapamycin Inhibitors and Posttransplantation Malignancy in Focus
|
Flechner, S.
|
|
2009
|
41 |
6S |
p. S42-S44
3 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2009
|
41 |
6S |
p. iii-
1 p.
|
artikel
|
| 4 |
Fighting Malignancy in Organ Transplant Recipients
|
Geissler, E.K.
|
|
2009
|
41 |
6S |
p. S9-S12
4 p.
|
artikel
|
| 5 |
Foreword
|
Oberbauer, Rainer
|
|
2009
|
41 |
6S |
p. S1-
1 p.
|
artikel
|
| 6 |
Mammalian Target of Rapamycin and Autosomal Dominant Polycystic Kidney Disease
|
Wüthrich, R.P.
|
|
2009
|
41 |
6S |
p. S18-S20
3 p.
|
artikel
|
| 7 |
Mammalian Target of Rapamycin and Diabetes: What Does the Current Evidence Tell Us?
|
Vodenik, B.
|
|
2009
|
41 |
6S |
p. S31-S38
8 p.
|
artikel
|
| 8 |
New Approaches to De Novo Immunosuppression and Steroid Elimination
|
Lebranchu, Y.
|
|
2009
|
41 |
6S |
p. S39-S41
3 p.
|
artikel
|
| 9 |
Optimizing Immunosuppression With Sirolimus in the First Year Posttransplantation: Experience in the United States
|
Weir, M.R.
|
|
2009
|
41 |
6S |
p. S13-S17
5 p.
|
artikel
|
| 10 |
Reducing the Risk of Left Ventricular Hypertrophy in Kidney Transplant Recipients: The Potential Role of Mammalian Target of Rapamycin
|
Paoletti, E.
|
|
2009
|
41 |
6S |
p. S3-S5
3 p.
|
artikel
|
| 11 |
Regulatory T Cells in Transplantation: What We Know and What We Do Not Know
|
Yeung, M.Y.
|
|
2009
|
41 |
6S |
p. S21-S26
6 p.
|
artikel
|
| 12 |
Where Did We Leave Off in 2008? Conclusions From The 8th International Symposium
|
Russ, G.
|
|
2009
|
41 |
6S |
p. S27-S30
4 p.
|
artikel
|
Tijdschrift beschrijving